相似文献
1
Nicotine-Friend or Foe? The Complex Interplay Between Its Role in Dependence, Harm Reduction, and Risk Communication.
Nicotine Tob Res. 2023 Jun 9;25(7):1227-1228. doi: 10.1093/ntr/ntad053.
2
[E-Cigarettes – Friend or Foe?].
Praxis (Bern 1994). 2015 Jul 1;104(14):739-43. doi: 10.1024/1661-8157/a002056.
3
Nicotine without smoke: fighting the tobacco epidemic with harm reduction.
Lancet. 2019 Aug 31;394(10200):718-720. doi: 10.1016/S0140-6736(19)31884-7.
4
Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
Clin Pharmacol Ther. 2011 Oct;90(4):491-3. doi: 10.1038/clpt.2011.191. Epub 2011 Aug 10.
5
Tobacco, nicotine and harm reduction.
Drug Alcohol Rev. 2011 Mar;30(2):119-23. doi: 10.1111/j.1465-3362.2010.00264.x.
6
Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.
Int J Drug Policy. 2021 Feb;88:103020. doi: 10.1016/j.drugpo.2020.103020. Epub 2020 Nov 8.
7
Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.
CNS Drugs. 2013 Dec;27(12):1007-19. doi: 10.1007/s40263-013-0116-4.
8
The fourth pillar of the Framework Convention on Tobacco Control: harm reduction and the international human right to health.
Public Health Rep. 2006 Sep-Oct;121(5):494-500. doi: 10.1177/003335490612100503.
9
Managing nicotine without smoke to save lives now: Evidence for harm minimization.
Prev Med. 2018 Dec;117:88-97. doi: 10.1016/j.ypmed.2018.06.010. Epub 2018 Jun 23.
10
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.
AIDS Behav. 2023 Feb;27(2):618-627. doi: 10.1007/s10461-022-03797-0. Epub 2022 Jul 22.
本文引用的文献
1
Youths' Perceptions of Nicotine Harm and Associations With Product Use.
Nicotine Tob Res. 2023 Jun 9;25(7):1302-1309. doi: 10.1093/ntr/ntad028.
2
Age, Period, and Cohort Analysis of Smoking Intensity Among Current Smokers in Malaysia, 1996-2015.
Nicotine Tob Res. 2023 Jun 9;25(7):1340-1347. doi: 10.1093/ntr/ntad035.
3
Development and Content Validation of a Questionnaire for Measuring Beliefs About Using Nicotine Replacement Therapy for Smoking Cessation in Pregnancy.
Nicotine Tob Res. 2023 Jun 9;25(7):1310-1318. doi: 10.1093/ntr/ntad030.
4
The Role of Emotion Differentiation in the Association Between Momentary Affect and Tobacco/Nicotine Craving in Young Adults.
Nicotine Tob Res. 2023 Jun 9;25(7):1261-1268. doi: 10.1093/ntr/ntad001.
5
Effects of Dextromethorphan on Nicotine-Induced Reward, Behavioral Sensitization, Withdrawal Signs, and Drug Seeking-Related Behavior in Rats.
Nicotine Tob Res. 2023 Jun 9;25(7):1251-1260. doi: 10.1093/ntr/ntac287.
6
Development of Dependence in Smokers and Rodents With Voluntary Nicotine Intake: Similarities and Differences.
Nicotine Tob Res. 2023 Jun 9;25(7):1229-1240. doi: 10.1093/ntr/ntac280.
7
Association of initial e-cigarette and other tobacco product use with subsequent cigarette smoking in adolescents: a cross-sectional, matched control study.
Tob Control. 2021 Mar;30(2):212-220. doi: 10.1136/tobaccocontrol-2019-055283. Epub 2020 Mar 17.
8
e-Cigarette Use Among Youth in the United States, 2019.
JAMA. 2019 Dec 3;322(21):2095-2103. doi: 10.1001/jama.2019.18387.
9
Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time-series analysis between 2006 and 2017.
Addiction. 2020 May;115(5):961-974. doi: 10.1111/add.14851. Epub 2019 Dec 4.
10
Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.
Trends Cardiovasc Med. 2016 Aug;26(6):515-23. doi: 10.1016/j.tcm.2016.03.001. Epub 2016 Mar 10.
Zotero 插件